Sugal & Damani

Which are the latest news on Sugal & Damani?

Why is Sugal & Damani Share Brokers Ltd falling/rising?

As of 19-Jul, Sugal & Damani Share Brokers Ltd's stock price is declining at 58.00, down 0.94%. The stock has significantly underperformed the Sensex, with a year-to-date drop of 19.22% compared to the Sensex's 8.30% decline.

As of 19-Jul, Sugal & Damani Share Brokers Ltd is experiencing a decline in its stock price, currently at 58.00, which reflects a change of -0.55 (-0.94%). The stock has been underperforming significantly compared to the benchmark Sensex, with a performance of -3.65% over the past week, while the Sensex has gained +0.75%. Over the last month, the stock has decreased by -5.31%, contrasting with the Sensex's increase of +1.29%. Year-to-date, the stock has fallen by -19.22%, compared to a lesser decline of -8.30% for the Sensex. <BR><BR>In the past year, Sugal & Damani has seen a dramatic drop of -50.00%, while the Sensex has only decreased by -4.99%. The stock has also been on a consecutive decline for the last three days, accumulating a total drop of -6.73% in this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Although there has been a slight increase in investor participation, with delivery volume rising by 8.2% against the 5-day average, the overall performance remains weak, leading to the current decline in stock price.

How big is Sugal & Damani?

As of 10th June, Sugal & Damani Share Brokers Ltd has a market capitalization of 38.00 Cr, with recent net sales of 19.66 Cr and a net profit of 4.12 Cr. The latest balance sheet shows shareholder's funds of 25.89 Cr and total assets of 32.64 Cr.

As of 10th June, Sugal & Damani Share Brokers Ltd has a market capitalization of 38.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 19.66 Cr and a Net Profit of 4.12 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 25.89 Cr and Total Assets of 32.64 Cr.

Who are in the management team of Sugal & Damani?

The management team of Sugal & Damani includes S Vinodh Kumar and Mahesh B Chandak as Executive Directors, S Kannadasan, Rajesh Gurdas Wadhwa, and Dhanesh Mrinalini as Independent Directors, S Prasan Chand Jain as a Director, and Radhika Maheshwari as Company Secretary & Compliance Officer.

The management team of Sugal & Damani includes the following individuals:<BR><BR>1. S Vinodh Kumar - Executive Director<BR>2. Mahesh B Chandak - Executive Director<BR>3. S Kannadasan - Independent Director<BR>4. S Prasan Chand Jain - Director<BR>5. Rajesh Gurdas Wadhwa - Independent Director<BR>6. Dhanesh Mrinalini - Independent Director<BR>7. Radhika Maheshwari - Company Secretary & Compliance Officer<BR><BR>If you need more specific information about any of these individuals or their roles, feel free to ask!

Who are the peers of the Sugal & Damani?

Sugal & Damani's peers include Ajcon Global, Kiduja India, Anupam Finserv, Glance Finance, Nagreeka Capital, JMJ Fintech, Biogen Pharma, MPIL Corporation, Swati Projects, and Amrapali Capital. Sugal & Damani has average management risk, excellent growth, and a 1-year return of -46.52%, higher than JMJ Fintech but lower than Amrapali Capital's 97.42%.

Peers: The peers of Sugal & Damani are Ajcon Global, Kiduja India, Anupam Finserv, Glance Finance, Nagreeka Cap., JMJ Fintech, Biogen Pharma, MPIL Corporation, Swati Projects, and Amrapali Capital.<BR><BR>Quality Snapshot: Excellent management risk is observed at Ajcon Global, Anupam Finserv, Glance Finance, JMJ Fintech, and Swati Projects, while Average management risk is found at Nagreeka Cap. and Sugal & Damani. Below Average management risk is noted for Kiduja India, Biogen Pharma, and JMJ Fintech, and the rest. Growth is Excellent at Sugal & Damani, JMJ Fintech, Anupam Finserv, and Amrapali Capital, while Good growth is seen at Nagreeka Cap. Average growth is found at Glance Finance, and Below Average growth is noted for Ajcon Global, Kiduja India, and Biogen Pharma, and the rest. Excellent capital structure is present at Ajcon Global, Anupam Finserv, Glance Finance, JMJ Fintech, Sugal & Damani, Swati Projects, and Amrapali Capital, while Below Average capital structure is noted for Nagreeka Cap. and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Amrapali Capital at 97.42%, while the lowest is JMJ Fintech at -65.44%. Sugal & Damani's 1-year return is -46.52%, which is higher than JMJ Fintech's but lower than Amrapali Capital's. Additionally, the six-month return is negative for Ajcon Global, JMJ Fintech, Biogen Pharma, and Sugal & Damani.

What does Sugal & Damani do?

Sugal & Damani Share Brokers Ltd is a Non Banking Financial Company specializing in share broking, depository services, and portfolio management. Founded in 1993, it reported net sales of 5 Cr and a net profit of 1 Cr for March 2026, with a market cap of INR 38 Cr.

Overview: <BR>Sugal & Damani Share Brokers Ltd operates in the Non Banking Financial Company (NBFC) sector, focusing on share broking, depository participant activity, and portfolio management services.<BR><BR>History: <BR>The company was incorporated on 7th May, 1993, and commenced business on 17th May, 1993. It changed its name from Sugal & Damani Finlease Limited to Sugal & Damani Share Brokers Limited on 23rd December, 2008. The most recent quarterly results reported net sales and net profit for March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 5 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 1 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 38 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 9.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.02 <BR>Return on Equity: 13.77% <BR>Price to Book: 1.21 <BR><BR>Contact Details: <BR>Address: City Centre Plaza 1st Floor, 7 Anna Salai Chennai Tamil Nadu : 600002 <BR>Tel: 91-044-28587105-08 <BR>Email: sugalshare_2008@rediffmail.com/grie <BR>Website: http://www.sugalshare.com

Should I buy, sell or hold Sugal & Damani Share Brokers Ltd?

When is the next results date for Sugal & Damani Share Brokers Ltd?

The next results date for Sugal & Damani Share Brokers Ltd is 29 May 2026.

The next results date for Sugal & Damani Share Brokers Ltd is scheduled for 29 May 2026.

Are Sugal & Damani Share Brokers Ltd latest results good or bad?

Sugal & Damani Share Brokers Ltd's latest results are poor, showing an 87.79% decline in net profit to ₹0.16 crore and a 63.44% drop in net sales to ₹2.15 crores, marking the lowest quarterly revenue recorded. The company is facing significant operational challenges, with negative operating profit and a sharp decrease in profitability margins.

The latest results for Sugal & Damani Share Brokers Ltd indicate a significant decline in performance, which can be characterized as bad. In Q3 FY26, the company reported a net profit of ₹0.16 crore, reflecting a dramatic 87.79% decrease compared to the previous quarter. Net sales also plummeted to ₹2.15 crores, down 63.44% quarter-on-quarter and 64.81% year-on-year, marking the lowest quarterly revenue in the available data.<BR><BR>The operating profit turned negative at ₹-0.04 crores, resulting in a negative operating margin of -1.86%. This is a stark contrast to the positive margins seen in earlier quarters. Additionally, the profit after tax (PAT) margin fell sharply to 7.44% from 22.28% in the previous quarter, indicating severe pressure on profitability.<BR><BR>Overall, these results highlight significant operational challenges for the company, with a troubling trend of declining revenues and profits. The financial performance has officially turned negative, suggesting that the company is facing substantial difficulties that need to be addressed.

How has been the historical performance of Sugal & Damani?

Sugal & Damani experienced significant growth from March 2024 to March 2025, with net sales rising to 25.34 Cr from 4.88 Cr, and profit after tax increasing to 4.75 Cr from 2.31 Cr. Despite a decrease in profit margins, the company showed improved cash flow and overall robust performance.

Answer:<BR>The historical performance of Sugal & Damani shows significant growth from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Sugal & Damani reported net sales of 25.34 Cr, a substantial increase from 4.88 Cr in March 2024. Total operating income also rose to 25.34 Cr from 4.88 Cr, while total expenditure excluding depreciation increased to 19.61 Cr from 2.78 Cr. The operating profit (PBDIT) grew to 6.53 Cr from 3.60 Cr, and profit before tax reached 6.34 Cr, up from 3.00 Cr. Consequently, profit after tax rose to 4.75 Cr from 2.31 Cr, leading to an earnings per share (EPS) increase to 7.6 from 3.7. The operating profit margin decreased to 22.61% from 43.03%, and the profit after tax margin fell to 18.75% from 47.34%. On the balance sheet, total assets increased to 32.64 Cr from 27.49 Cr, with total liabilities rising to 32.64 Cr from 27.49 Cr. Cash flow from operating activities improved to 13.00 Cr from -6.00 Cr, resulting in a net cash inflow of 2.00 Cr compared to no cash inflow in the previous year. Overall, Sugal & Damani demonstrated a robust performance with significant growth in sales, profits, and cash flow.

Is Sugal & Damani overvalued or undervalued?

As of November 4, 2025, Sugal & Damani is considered undervalued with a valuation grade of attractive, a PE ratio of 10.63, an EV to EBIT of 8.28, a ROCE of 24.99%, and a one-year return of 56.22%, significantly outperforming the Sensex's 5.94%.

As of 4 November 2025, Sugal & Damani's valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently deemed undervalued, supported by a PE ratio of 10.63, an EV to EBIT of 8.28, and an impressive ROCE of 24.99%. When compared to peers, Sugal & Damani's valuation stands out; for instance, Bajaj Finance is classified as very expensive with a PE ratio of 37.67, while Life Insurance is very attractive with a PE of 11.76.<BR><BR>The recent performance of Sugal & Damani has also been notable, with a one-year return of 56.22%, significantly outpacing the Sensex's return of 5.94% over the same period. This strong performance, coupled with its attractive valuation metrics, reinforces the conclusion that Sugal & Damani is currently undervalued in the market.

What is the technical trend for Sugal & Damani?

As of May 13, 2025, the technical trend is mildly bullish, supported by positive weekly MACD and KST indicators, although daily moving averages present some caution.

As of 13 May 2025, the technical trend has changed from sideways to mildly bullish. The weekly MACD and KST are both bullish, supporting the positive outlook. Bollinger Bands also indicate a bullish stance on both weekly and monthly time frames. However, the daily moving averages are mildly bearish, which introduces some caution. The Dow Theory reflects a mildly bullish trend on both weekly and monthly levels. Overall, the current technical stance is mildly bullish, driven primarily by the strong weekly indicators, despite the mixed signals from daily moving averages.

Who are the top shareholders of the Sugal & Damani?

The top shareholders of Sugal & Damani are primarily promoters, with Vinodh Kumar S holding 23.18%. Lalith Chandak is the largest public shareholder at 2.3%, while individual investors collectively own 21.46% of the shares.

The top shareholders of Sugal & Damani are primarily the promoters, with Vinodh Kumar S holding the highest stake at 23.18%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Lalith Chandak, who holds 2.3%. Additionally, individual investors collectively hold 21.46% of the shares.

Has Sugal & Damani declared dividend?

Sugal & Damani Share Brokers Ltd has declared a 2% dividend, amounting to 0.20 per share, with an ex-date of July 15, 2013. Despite this, the dividend yield is 0%, as the company has shown substantial price returns across all periods.

Sugal & Damani Share Brokers Ltd has declared a 2% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 2%<BR>- Amount per share: 0.20<BR>- Ex-date: 15 Jul 13<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was 7.88%, the dividend return was 0%, resulting in a total return of 7.88%.<BR><BR>For the 1-year period, the price return was 168.66%, the dividend return was 0%, leading to a total return of 168.66%.<BR><BR>Over the 2-year period, the price return was 502.44%, with a dividend return of 0%, culminating in a total return of 502.44%.<BR><BR>In the 3-year period, the price return was 407.39%, the dividend return was 0%, which resulted in a total return of 407.39%.<BR><BR>During the 4-year period, the price return was 896.66%, with no dividend return, giving a total return of 896.66%.<BR><BR>For the 5-year period, the price return was 1363.79%, and the dividend return was 0%, resulting in a total return of 1363.79%.<BR><BR>Overall, while Sugal & Damani has declared a dividend, the dividend yield remains at 0%. The company has shown significant price returns across all periods, indicating strong performance despite the lack of ongoing dividend payments.